Progesterone increases the expression of myelin basic protein and the number of cells showing NG2 immunostairling in the lesioned spinal cord

被引:61
作者
Labombarda, F
Gonzalez, S
Deniselle, MCG
Garay, L
Guennoun, R
Schumacher, M
De Nicola, AF
机构
[1] Univ Buenos Aires, Inst Biol & Med Expt, Lab Neuroendocrine Biochem, RA-1428 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Fac Med, Dept Human Biochem, RA-1428 Buenos Aires, DF, Argentina
[3] Hop Bicetre, INSERM, U488, Le Kremlin Bicetre, France
关键词
myelin basic protein; neuroprotection; NG(2)+ cells; oligodendrocytes; progesterone; spinal cord injury;
D O I
10.1089/neu.2006.23.181
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
It is now widely accepted that progesterone (PROG) brings neuroprotection in lesions of the peripheral and central nervous system. Spinal cord trauma leads to neuronal degeneration, astrogliosis, demyelination, and proliferation of oligodendrocyte-precursor cells (OPCs). In this work, we studied the effects of PROG on myelin-related parameters in rats with complete spinal cord transection (TRX). To this end, sham-operated controls and rats with TRX at thoracic level T10 received vehicle or PROG (4 mg/kg/day) during 3 days. Three variables were measured in the lumbar L4 region below the lesion: (1) expression of myelin basic protein (MBP) at the protein and mRNA levels; (2) density of NG(2)-immunopositive cells as markers for OPCs; and (3) number of cells immunopositive for RIP, an antibody staining mature oligodendrocytes. TRX decreased MBP immunostaining in the corticospinal tract (CST) and dorsal ascending tract (DAT) but not the ventral funiculus'(VF). NG(2)(+) cells, which were detected in low number in controls, increased after TRX in the gray and white matter. RIP-positive cell number, however, remained unchanged. PROG treatment of rats with TRX enhanced the expression of MBP protein and mRNA in CST and DAT, but not VF and highly stimulated the number of cells showing NG(2) immunostaining over untreated lesioned rats. Instead, density of RIP positive cells was similar in the PROG-treated and untreated lesioned groups. We propose that PROG effects on expression of MBP and the number of NG2 immunopositive cells may contribute to neuroprotection, as they go in parallel with previous results showing enhanced biochemical and morphological parameters of motoneurons of animals with TRX receiving PROG treatment.
引用
收藏
页码:181 / 192
页数:12
相关论文
共 50 条
[1]   Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats [J].
Azcoitia, I ;
Leonelli, E ;
Magnaghi, V ;
Veiga, S ;
Garcia-Segura, LM ;
Melcangi, RC .
NEUROBIOLOGY OF AGING, 2003, 24 (06) :853-860
[2]   Review of current evidence for apoptosis after spinal cord injury [J].
Beattie, MS ;
Farooqui, AA ;
Bresnahan, JC .
JOURNAL OF NEUROTRAUMA, 2000, 17 (10) :915-925
[3]  
Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299
[5]  
BUNGE RP, 1993, ADV NEUROL, V59, P75
[6]   Identification of the adult resting progenitor cell by autoradiographic tracking of oligodendrocyte precursors in experimental CNS demyelination [J].
Carroll, WM ;
Jennings, AR ;
Ironside, LJ .
BRAIN, 1998, 121 :293-302
[7]   Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation [J].
Chan, JR ;
Phillips, LJ ;
Glaser, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10459-10464
[8]   Neurotrophins are key mediators of the myelination program in the peripheral nervous system [J].
Chan, JR ;
Cosgaya, JM ;
Wu, YJ ;
Shooter, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) :14661-14668
[9]   Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo [J].
Ciriza, I ;
Azcoitia, I ;
Garcia-Segura, LM .
JOURNAL OF NEUROENDOCRINOLOGY, 2004, 16 (01) :58-63
[10]   Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease [J].
Deniselle, MCG ;
López-Costa, JJ ;
Saavedra, JP ;
Pietranera, L ;
Gonzalez, SL ;
Garay, L ;
Guennoun, R ;
Schumacher, M ;
De Nicola, AF .
NEUROBIOLOGY OF DISEASE, 2002, 11 (03) :457-468